12 - 14 November, 2019 | Hilton Munich City, Munich, Germany

Agenda Day 2

8:30 am - 9:00 am Registration and Welcome Coffee

9:10 am - 9:50 am AI IN R&D FOR DRUG DISCOVERY

  • Take a step back from the clinical data and look at how different technologies are applied in drug discovery
  • Identify why the right data, technology and question is paramount to a successful AI-based initiative
  • What to expect once AI is fully embraced by health sciences
Leonardo Rodrigues, VP, AI & Machine Learning at BERG Health

Leonardo Rodrigues

VP, AI & Machine Learning
BERG Health

9:50 am - 10:30 am SPOTLIGHT SESSION: UTILISING IMAGE BASED ANALYSIS TO FACILITATE EFFECTIVE REAL TIME DECISION MAKING

  • Use ML-guided image-based analysis to provide an opportunity to inform real-time decision making in an adaptive design construct
  • Consider using this approach to guide an adaptive design platform for TB regimen development using image analysis of X-ray data
  • Conduct discrete-event simulations to expose the relevant time dependencies to evaluate the necessary operating characteristics of the trial and data management systems

Jeff Barrett, Head Quantitative Sciences at Bill & Melinda Gates Medical Research Institute

Jeff Barrett

Head Quantitative Sciences
Bill & Melinda Gates Medical Research Institute

10:30 am - 11:00 am Networking Coffee Break

With the need for efficiency to utilise data at an all time high, there’s a huge boom within the start-up space, offering innovative solutions to effectively meet these requirements. This session is designed to generate insight into emerging technologies in the industry and in a bite size showcase, demonstrating the benefits they can bring to your data processes.
Delegates will enjoy 3 x consecutive 20-minute sessions in which the start-ups will educate you about their platform, followed by Q&A. This is one not to miss to ensure you stay at the forefront of innovation!

Vibhor Gupta, Director and Founder at PangaeaData.AI

Vibhor Gupta

Director and Founder
PangaeaData.AI

Aaron Leibtag, CEO & Co-Founder at Pentavere

Aaron Leibtag

CEO & Co-Founder
Pentavere

Nataraj Dasgupta, VP, Advanced Analytics & Data Science at RxDataScience

Nataraj Dasgupta

VP, Advanced Analytics & Data Science
RxDataScience

1:00 pm - 2:00 pm Networking Lunch

2:00 pm - 2:40 pm THE CHALLENGES SURROUNDING DATA SECURITY FOLLOWING THE ARRIVAL OF GDPR

  • Understand the key ethical and governance issues in proposed new technologies and approaches to data handling to help develop trusted and transparent environments for data reuse, grounded in FAIR principles
  • Identify and mitigate risks to rights and freedoms of participants and researchers with a proportionate approach to meeting risks and challenges
  • Strike the right balance between the need for data to flow to help improve care and outcomes with demonstrating trustworthiness in data use
Nathan Lea, Honorary Data Science Facilitator at UCL

Nathan Lea

Honorary Data Science Facilitator
UCL

2:40 pm - 3:20 pm COMBINING DATA TO ESTIMATE THE NUMBER OF UNIQUE PATIENTS TAKING A PRODUCT

  • Identify how many unique patients are taking (or have taken) a product, which is important for safety but not previously available within sales data
  • Learn how to use claims data to get a good estimate of the number of unique patients exposed to a drug
  • Discuss validation of code that will be used for regulatory purposes, and how to get good results from 3rd parties hired to do technical work
Matt Wiener, Director, Informatics & Predictive Sciences at Celgene

Matt Wiener

Director, Informatics & Predictive Sciences
Celgene

3:20 pm - 3:50 pm Networking Coffee Break

3:50 pm - 4:30 pm TOWARDS THE VISUALISATION, MONITORING AND CONTROL OF MULTIVARIATE PHARMACEUTICAL PROCESSES

  • Discuss multivariate data visualisation and look towards Pharmaceutical Lean Six Sigma
  • Explore Pharma 4.0 and it’s applications such as virtual sensors, automation and quality predictive control
  • Extract information from the data to ensure the manufacture of consistently high quality product and obtain early warning of changes in process behaviour, process faults and non-conforming operation
Julian Morris, Technical Director at Centre for Process Analytics and Control Technology (CPACT)

Julian Morris

Technical Director
Centre for Process Analytics and Control Technology (CPACT)

4:30 pm - 5:00 pm CASE STUDY: INNOVATING REAL WORLD EVIDENCE IN NEUROSCIENCE

  • Initiate large cohort studies to capture standardized qualitative information
  • Understand how you can use this as your own real world data source to generate data
  • Process and analyse data previously unattainable (such as speed information or physical function)
Carl de Moor, Senior Director, Head, Global Real World Evidence Strategy and Analytics at Biogen

Carl de Moor

Senior Director, Head, Global Real World Evidence Strategy and Analytics
Biogen

5:00 pm - 5:00 pm End of Day Two